ASP International (Advanced Sterilization Products) in collaboration with Fujifilm Healthcare Europe announced that the Ultra GI Cycle has earned CE mark approval.

The Ultra GI Cycle is the latest innovation for the STERRAD 100NX sterilizer with ALLClear technology. This CE mark represents an advancement to elevate patient safety in healthcare facilities and address the challenges related to traditional reprocessing methods.

“This is a meaningful step forward in our mission to make duodenoscope reprocessing safer across Europe,” said Chad Rohrer, president of ASP. “By bringing hydrogen peroxide gas plasma sterilization into routine practice, we’re giving clinicians greater confidence to focus on what matters most—their patients.”

The company’s immediate focus is to work with medical device manufacturers to ensure new duodenoscope models are designed to be compatible with hydrogen peroxide.

“The addition of the new FUJIFILM duodenoscope models ED-840T and ED-840XT to the ULTRA GI Cycle further expands the breakthrough technology platform and demonstrates ASP’s commitment to innovation and partnership with FUJIFILM Healthcare,” said ASP’s VP of R&D Pierre Emeric. “Most importantly, current ASP customers who already have a STERRAD 100NX Sterilizer with ALLClear Technology can access the benefits of the ULTRA GI Cycle via a cycle upgrade on their existing equipment and can continue maximizing the value of their investment.”

“Duodenoscopes have historically posed infection control challenges due to their contamination rates,” added Ivan Salgo, MD, VP and chief medical officer at ASP. “The partnership between ASP and FUJIFILM Healthcare has resulted in a sterilization approach that exceeds current industry benchmarks, providing healthcare professionals with an advanced solution to elevate patient safety standards.”